Assertio Holdings, Inc. Contracts & Agreements

40 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Assertio Holdings, Inc. Amended and Restated 2014 Omnibus Incentive Plan (Effective May 23, 2024)
Bonus & Incentive Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2025
Assertio Holdings, Inc. Amended and Restated Annual Bonus Plan (2025)
Bonus & Incentive Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2025
Assertio Holdings, Inc. CEO Employment Agreement with Brendan O’Grady (May 2024)
Employment Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2024
Assertio Holdings, Inc. Management Continuity Agreement with Brendan O’Grady
Change of Control Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2024
Assertio Holdings, Inc. Nonemployee Director Compensation and Grant Policy (Effective May 8, 2024)
Compensation Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2024
Assertio Holdings, Inc. Amended and Restated Annual Bonus Plan (2024)
Bonus & Incentive Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2024
Third Amendment to Supply Agreement – Rolontis between Spectrum Pharmaceuticals, Inc. and Hanmi Pharmaceuticals Co., Ltd.
Supply Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2024
Letter of Binding Understanding for Supply of Rolvedon Drug Substance between Spectrum Pharmaceuticals, Inc. (Assertio Holdings, Inc.) and Hanmi Pharmaceutical Co., Ltd.
Supply Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2024
Assertio Holdings, Inc. Interim CEO Employment Agreement with Heather Mason (January 2024)
Employment Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2024
Contingent Value Rights Agreement between Assertio Holdings, Inc. and Computershare Inc. (July 31, 2023)
Assertio Holdings, Inc.
Pharmaceuticals
DE
2023
Assertio Holdings, Inc. Amended and Restated 2014 Omnibus Incentive Plan (as of May 4, 2022)
Bonus & Incentive Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2023
Agreement and Plan of Merger among Assertio Holdings, Inc., Spade Merger Sub 1, Inc., and Spectrum Pharmaceuticals, Inc. dated April 24, 2023
Merger Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2023
Assertio Holdings, Inc. Amended and Restated 2014 Omnibus Incentive Plan – Stock Option and Restricted Stock Unit Award Notice
Bonus & Incentive Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2023
Assertio Holdings, Inc. Restricted Stock Unit Inducement Award Agreement
Equity Distribution Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2023
Assertio Holdings, Inc. Amended and Restated Annual Bonus Plan (2023)
Bonus & Incentive Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2023
Assertio Holdings, Inc. Nonemployee Director Compensation and Grant Policy
Compensation Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2023
Assertio Holdings, Inc. Convertible Notes Exchange Agreement with Noteholders
Exchange Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2023
Indenture for 6.50% Convertible Senior Notes due 2027 between Assertio Holdings, Inc. and U.S. Bank Trust Company, N.A.
Indenture Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2022
Assertio Holdings, Inc. $25,000,000 Common Stock Sales Agreement with Roth Capital Partners, LLC (December 17, 2021)
Sales Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2022
Asset Purchase Agreement by and between Otter Pharmaceuticals, LLC, Antares Pharma, Inc., and Assertio Holdings, Inc. dated December 15, 2021
Purchase Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2022
Second Supplemental Indenture to 13% Senior Secured Notes Due 2024—Otter Pharmaceuticals, LLC Joinder as Guarantor
Indenture Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2022
Assertio Holdings, Inc. Management Continuity Agreement with Employee
Change of Control Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2022
Assertio Holdings, Inc. Amended and Restated Annual Bonus Plan (2022)
Bonus & Incentive Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2022
Separation Agreement and Release of Claims between Todd N. Smith and Assertio Management, LLC
Separation Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2022
Separation Agreement and Release of Claims between Mark Strobeck and Assertio Management, LLC
Separation Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2022
Amendment No. 3 to Collaborative License, Exclusive Manufacture and Global Supply Agreement between Zyla Life Sciences and Cosette Pharmaceuticals, Inc.
Collaboration Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2021
Separation Agreement and Release of Claims between Todd N. Smith and Assertio Management, LLC
Separation Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2021
Separation Agreement and Release of Claims between Mark Strobeck and Assertio Management, LLC
Separation Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2021
Securities Purchase Agreement between Assertio Holdings, Inc. and Purchasers (February 10, 2021)
Purchase Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2021
Placement Agency Agreement between Assertio Holdings, Inc. and Roth Capital Partners, LLC (February 2021)
Equity Distribution Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2021
Securities Purchase Agreement between Assertio Holdings, Inc. and Purchasers (February 5, 2021)
Purchase Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2021
Placement Agency Agreement between Assertio Holdings, Inc. and Roth Capital Partners, LLC (February 2021)
Underwriting Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2021
Registration Rights Agreement between Assertio Holdings, Inc. and Investors (May 20, 2020)
Registration Rights Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2020
Assertio Holdings, Inc. Common Stock Purchase Warrant Agreement (Form)
Warrant Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2020
Employment Agreement between Zyla Life Sciences and Todd N. Smith (President and CEO)
Employment Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2020
Assertio/Zyla Life Sciences Executive Employment Offer Letter with Mark Strobeck (June 2020)
Employment Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2020
Assertio/Zyla Life Sciences Employment Offer Letter to Megan C. Timmins (Senior Vice President, General Counsel and Secretary)
Employment Agreements
Assertio Holdings, Inc.
Pharmaceuticals
2020
Zyla Life Sciences Management Continuity Agreement with Employee (June 23, 2020)
Change of Control Agreements
Assertio Holdings, Inc.
Pharmaceuticals
DE
2020
Transition and Consulting Agreement between Stanley Bukofzer and Assertio Therapeutics, Inc.
Transition Agreements
Assertio Holdings, Inc.
Pharmaceuticals
IL
2020
First Supplemental Indenture among Zyla Life Sciences, Assertio Holdings, Inc., and Wilmington Savings Fund Society, FSB, dated May 20, 2020
Indenture Agreements
Assertio Holdings, Inc.
Pharmaceuticals
NY
2020